Cargando…

Biomarkers and Targeted Therapy in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) constitutes 90% of pancreatic cancers. PDAC is a complex and devastating disease with only 1%–3% survival rate in five years after the second stage. Treatment of PDAC is complicated due to the tumor microenvironment, changing cell behaviors to the mesenchymal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karandish, Fataneh, Mallik, Sanku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847554/ https://www.ncbi.nlm.nih.gov/pubmed/27147897 http://dx.doi.org/10.4137/BiC.s34414

Ejemplares similares

Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids
por: Karandish, Fataneh, et al.
Publicado: (2016)

Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy
por: Grapa, Cristiana Maria, et al.
Publicado: (2021)

Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation
por: Nyren-Erickson, Erin K, et al.
Publicado: (2014)

Targeted Therapies for Pancreatic Cancer
por: Amanam, Idoroenyi, et al.
Publicado: (2018)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
por: Schlick, Konstantin, et al.
Publicado: (2021)

Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification
por: Shreffler, Jacob W., et al.
Publicado: (2019)

Pancreatic Cancer: BRCA Targeted Therapy and Beyond
por: Keane, Fergus, et al.
Publicado: (2023)

Ovarian Cancer: Biomarkers and Targeted Therapy
por: Radu, Mihaela Raluca, et al.
Publicado: (2021)

3D Printability of Alginate-Carboxymethyl Cellulose Hydrogel
por: Habib, Ahasan, et al.
Publicado: (2018)

Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes
por: Mamnoon, Babak, et al.
Publicado: (2021)

Role of the Substrate Specificity-Defining Residues of Human SIRT5 in Modulating the Structural Stability and Inhibitory Features of the Enzyme
por: Yu, Junru, et al.
Publicado: (2016)

Advances in pancreatic cancer biomarkers
por: Hasan, Syed, et al.
Publicado: (2019)

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
por: Wang, Xinning, et al.
Publicado: (2021)

An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic
por: Dailey, Kaitlin M., et al.
Publicado: (2023)

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
por: Wrona, Ewa, et al.
Publicado: (2021)

Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy
por: Alhalhooly, Lina, et al.
Publicado: (2021)

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer
por: Zhang, Lun, et al.
Publicado: (2016)

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
por: Mishra, Prachi, et al.
Publicado: (2021)

Proteomics-Driven Biomarkers in Pancreatic Cancer
por: Ramalhete, Luís, et al.
Publicado: (2023)

Relevance of Micro-leakage to Orthodontic Bonding - a Review
por: M, Karandish
Publicado: (2016)

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009)

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
por: Fillat, Cristina, et al.
Publicado: (2011)

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
por: Chiorean, Elena Gabriela, et al.
Publicado: (2015)

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
por: Roacho-Pérez, Jorge A., et al.
Publicado: (2021)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022)

Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
por: Abou Khouzam, Raefa, et al.
Publicado: (2023)

Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?
por: Halle-Smith, James M., et al.
Publicado: (2023)

Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
por: Ideno, Noboru, et al.
Publicado: (2020)

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
por: Sturm, Niklas, et al.
Publicado: (2022)

Arginine metabolism: a potential target in pancreatic cancer therapy
por: Yang, Jin-Shou, et al.
Publicado: (2021)

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Senescent T cells: a potential biomarker and target for cancer therapy
por: Zhang, Jie, et al.
Publicado: (2021)

Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
por: Verma, Mukesh
Publicado: (2010)

Recent advances in targeted therapy for pancreatic adenocarcinoma
por: Fang, Yu-Ting, et al.
Publicado: (2023)

Current State of “Omics” Biomarkers in Pancreatic Cancer
por: Turanli, Beste, et al.
Publicado: (2021)

LncRNAs: Novel Biomarkers for Pancreatic Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Advances in biomarkers and techniques for pancreatic cancer diagnosis
por: Wu, Haotian, et al.
Publicado: (2022)

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
por: Pezzilli, Raffaele, et al.
Publicado: (2020)

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Biomarker development in MET-targeted therapy
por: Zhang, Yanni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p15317tpiljl3rdolq5rcu32hh